The FDA has approved a PD-1 blockade treatment regimen for certain patients with advanced stomach and gastroesophageal cancer. The U.S. Food and Drug Administration (FDA) has granted traditional approval to pembrolizumab (Keytruda) in combination...
Pickleball encourages more activity in cancer survivors, and urine test detects aggressive prostate cancer.
Multiple myeloma can be tricky to treat, but many treatment options exist, and new research is constantly supporting more.
HPV vaccine credited for 80% drop in lesions that can lead to cervical cancer, and FDA approves targeted therapy for esophageal cancer.
Natalie Snider-Hoy, a PhD candidate at Wayne State University, attended AACR Early-career Hill Day 2025 to advocate for sustained NIH funding.
Cancer screenings are key to saving lives. Take colonoscopies, for example, which are estimated to reduce colorectal cancer risk by about 30%. This is because undergoing colonoscopies as recommended (every 10 years beginning at...
The FDA has approved a new combination regimen for certain patients with esophageal cell squamous cell carcinoma. The U.S. Food and Drug Administration (FDA) has approved tislelizumab-jsgr (Tevimbra) in combination with chemotherapy for the...
Exercise associated with increased survival after colon cancer, and screening costs remain a hurdle for women with dense breasts.
Men with metastatic prostate cancer urged to ask questions about care, and early-phase study suggests benefit of pancreatic cancer vaccine.
This month, the editors of AACR's journals show their love for studies about CAR T-cell efficacy, breast cancer risk, and more.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More